Çakmak Görür, N. (2020). Targeting the hematopoietic stem cell antigen FLT3 by high-affinity T cell receptor for the treatment of high-risk acute myeloid leukemia.
Chicago-Zitierstil (17. Ausg.)Çakmak Görür, Neşe. Targeting the Hematopoietic Stem Cell Antigen FLT3 by High-affinity T Cell Receptor for the Treatment of High-risk Acute Myeloid Leukemia. Berlin, 2020.
MLA-Zitierstil (9. Ausg.)Çakmak Görür, Neşe. Targeting the Hematopoietic Stem Cell Antigen FLT3 by High-affinity T Cell Receptor for the Treatment of High-risk Acute Myeloid Leukemia. 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.